Access to Orphan Drugs: A Comprehensive Review of Legislations, Regulations and Policies in 35 Countries.
OBJECTIVE:To review existing regulations and policies utilised by countries to enable patient access to orphan drugs. METHODS:A review of the literature (1998 to 2014) was performed to identify relevant, peer-reviewed articles. Using content analysis, we synthesised regulations and policies for acce...
Main Authors: | Todd Gammie, Christine Y Lu, Zaheer Ud-Din Babar |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4599885?pdf=render |
Similar Items
-
Forming a medicines pricing policy for low and middle-income countries (LMICs): the case for Pakistan
by: Zaheer-Ud-Din Babar
Published: (2022-12-01) -
Pharmaceutical policies in Australia and New Zealand
by: Zaheer-Ud-Din Babar
Published: (2015-12-01) -
Ten recommendations to improve pharmacy practice in low and middle-income countries (LMICs)
by: Zaheer-Ud-Din Babar
Published: (2021-12-01) -
Clinical aspects of reimbursement policies for orphan drugs in Central and Eastern European countries
by: Szczepan Jakubowski, et al.
Published: (2024-03-01) -
An Insight Of The Policy And Access To Orphan Drugs For Treating Rare Disease In Malaysia: Quantitative And Qualitative Analysis
by: Supian, Azuwana
Published: (2022)